Get the Stockscreener App
1.02
0.98%
-0.00
Clearmind Medicine Inc stock is traded at $1.02, with a volume of 13,911.
It is down -0.98% in the last 24 hours and up +3.91% over the past month.
Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.
See More
Previous Close:
$1.02
Open:
$1
24h Volume:
13,911
Relative Volume:
0.02
Market Cap:
$4.35M
Revenue:
-
Net Income/Loss:
$-6.78M
P/E Ratio:
-0.0239
EPS:
-42.6996
Net Cash Flow:
$-4.67M
1W Performance:
+2.33%
1M Performance:
+3.91%
6M Performance:
-28.37%
1Y Performance:
-11.40%
1-Day Range:
$1.00
$1.02
1-Week Range:
$0.98
$1.05
52-Week Range:
$0.80
$2.18
Clearmind Medicine Inc Stock (CMND) Company Profile
Compare CMND with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CMND
Clearmind Medicine Inc
|
1.02 | 5.49M | 0 | -6.78M | -4.67M | -42.70 |
|
VRTX
Vertex Pharmaceuticals Inc
|
392.36 | 101.51B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
576.64 | 59.52B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.25 | 56.69B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
648.31 | 39.57B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
314.12 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Clearmind Medicine Inc Stock (CMND) Latest News
What makes Clearmind Medicine Inc. stock price move sharplySell Signal & Low Drawdown Trading Techniques - Newser
Can a trend reversal in Clearmind Medicine Inc. lead to recoveryWeekly Trend Report & Smart Money Movement Alerts - Newser
Clearmind Medicine Inc. stock chart pattern explained2025 Volume Leaders & Community Verified Watchlist Alerts - Newser
Will Volume Confirm Reversal in Clearmind Medicine Inc.2025 Technical Patterns & Verified Momentum Stock Alerts - sundaytimes.kr
Clearmind Medicine Inc. stock trendline breakdown2025 Volatility Report & Growth Focused Entry Point Reports - Newser
Should you wait for a breakout in Clearmind Medicine Inc.July 2025 Institutional & High Conviction Buy Zone Picks - Newser
Can Clearmind Medicine Inc. rally from current levelsQuarterly Portfolio Review & Risk Controlled Daily Plans - Newser
Trend analysis for Clearmind Medicine Inc. this weekWeekly Gains Report & Real-Time Market Sentiment Alerts - Newser
How Clearmind Medicine Inc. stock performs during market volatilityIndex Update & Weekly High Return Stock Forecasts - Newser
Institutional scanner results for Clearmind Medicine Inc.Portfolio Return Summary & Safe Capital Growth Stock Tips - Newser
Risk vs reward if holding onto Clearmind Medicine Inc.Weekly Signal Report with Trend Summary - Newser
Why Clearmind Medicine Inc. stock attracts strong analyst attentionBreakout Stocks with Huge Upside - thegnnews.com
Exit strategy if you’re trapped in Clearmind Medicine IncFree Smart Trade Plans With Risk Protection - Newser
Clearmind Medicine Announces Publication of International Patent Application for Novel Combination Therapy Targeting Obesity and High Blood Sugar - MarketScreener
Clearmind Medicine Inc. stock retracement – recovery analysis5-Year Price Trend Summary and Analysis - Newser
Short interest data insights for Clearmind Medicine Inc.Entry Confirmation Based on Volatility Analysis - Newser
Can you recover from losses in Clearmind Medicine Inc.Daily Stock Watch Summary with Key Insights - Newser
Will Clearmind Medicine Inc. benefit from macro trendsMomentum-Based Prediction for Quick Returns - Newser
Can volume confirm reversal in Clearmind Medicine Inc.Real Market Tracker with Price Action Tools - Newser
Is it time to cut losses on Clearmind Medicine Inc.Buy List With Technical Entry Triggers - Newser
Published on: 2025-08-09 23:23:05 - Newser
Clearmind Medicine files international patent application under PCT - MSN
How to use a screener to detect Clearmind Medicine Inc. breakoutsTrend Analysis for Safer Market Entries - Newser
How Clearmind Medicine Inc. stock reacts to Fed policy changesHigh Win Rate Trading Opportunities Detected - metal.it
Clearmind Medicine Inc. stock outlook for YEARTechnical Insight Guide for Safer Trades - Newser
SciSparc-Clearmind collab leads to international patent application - TipRanks
Clearmind Medicine Inc Stock (CMND) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.37%
0.57%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):